Antiplatelet activity of 3-butyl-6-bromo-1(3H)-isobenzofuranone on rat platelet aggregation

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 1, 2012, Pages 64-73

  Ma, Feifei ^a   Gao, Yuan ^a   Qiao, Hailing ^a   Hu, Xiangjie ^a   Chang, Junbiao ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

3 butyl 6 bromo 1(3H) isobenzofuranone; Arachidonic acid; Ex vivo; In vitro; Platelet aggregation; Thrombosis

Indexed keywords

3 BUTYL 6 BROMO 1(3H) ISOBENZOFURANONE; 6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; CALCIUM ION; CYCLIC AMP; CYCLIC GMP; MALONALDEHYDE; NITRIC OXIDE; PHTHALIDE DERIVATIVE; SEROTONIN; THROMBOXANE A2; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM MOBILIZATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EX VIVO STUDY; IC 50; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; MALE; PHTHALIC ANHYDRIDES; PILOT PROJECTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84858866004     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0647-9     Document Type: Article

References (41)

1. Bamford JM (2000) The role of the clinical examination in the subclassification of stroke. J Cerebrovasc Dis 10:2-4
2. Huo YQ, Ley KF (2004) Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 14(1):18-22
3. Furie B, Furie BC (2005) Thrombus formation in vivo. J Clin Invest 115(12):3355-3362 (Pubitemid 43121819)
4. Li S, Li X, Li J, Deng X, Li Y, Cong Y (2007) Experimental arterial thrombosis regulated by androgen and its receptor via modulation of platelet activation. Thromb Res 121(1):127-134 (Pubitemid 350026003)
5. Kulkarni S, Dopheide SM, Yap CL, Ravanat C, Freund M, Mangin P, Heel KA, Street A, Harper IS, Lanza F, Jackson SP (2000) A revised model of platelet aggregation. J Clin Invest 105(6):783-791 (Pubitemid 30164117)
6. Ramasamy I (2004) Inherited bleeding disorders: disorders of platelet adhesion and aggregation. Crit Rev Oncol Hematol 49:1-35
7. Fong J, Cheng-Ching E, Hussain MS, Katzan I, Gupta R (2011) Predictors of biochemical aspirin and clopidogrel resistance in patients with ischemic stroke. J Stroke Cerebrovasc Dis 20(3):227-230
8. Fitzgerald R, Pirmohamed M (2011) Aspirin resistance: effect of clinical, biochemical and genetic factors. Pharmacol Ther 130(2):213-225
9. Peng Y, Xing CH, Lemere CA, Chen GQ, Wang L, Feng YP, Wang XL (2008) l-3-n-Butylphthalide amelioratesß-amyloid-induced neuronal toxicity in cultured neuronal cells. Neurosci Lett 434:224-229
10. Peng Y, Zeng XK, Feng YP, Wang XL (2004) Antiplatelet and antithrombotic activity of L-3-n-butylphthalide in rats. J Cardiovasc Pharmacol 43:876-881 (Pubitemid 38679610)
11. Gao Y, Zhang HW, Qiao HL, Wang W, Chang JB (2010) Protective effect of 3-butyl-6-bromo-1(3H) -isobenzofuranone on hydrogen peroxide-induced damage in PC12 cells. Brain Res 1358:239-247
12. Fan HY, Fu FH, Yang MY, Xu H, Zhang AH, Liu K (2010) Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb Res 126:17-22
13. Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and it's reversal. Nature 194:927-929
14. Jeng JH, Wu HL, Lin BR, Lan WH, Chang HH, Ho YS, Lee PH, Wang YJ, Wang JS, Chen YJ, ChangMC(2007) Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Atherosclerosis 191(2):250-258
15. Nishimura T, Yamamoto T, Komuro Y, Hara Y (1995) Antiplatelet functions of a stable prostacyclin analog, SM-10906 are exerted by its inhibitory effect on inositol 1,4,5-trisphosphate production and cytosolic Ca++ increase in rat platelets stimulated by thrombin. Thromb Res 79(3):307-317
16. Gale DD, Hofer P, Spina D, Seeds EA, Banner KH, Harrison S, Douglas G, Matsumoto T, Page CP, Wong RH, Jordan S, Smith F, Banik N, Halushka PV, Cavalla D, Rotshteyn Y, Kyle DJ, Burch RM, Chasin M (2003) Pharmacology of a new cyclic nucleotidephosphodiesterase type 4 inhibitor, V11294. Pulm Pharmacol Ther 16(2):97-104 (Pubitemid 36369398)
17. Schaeffer J, Blaustein MP (1989) Platelet free calcium concentrations measured with fura-2 are influenced by the transmembrane sodium gradient. Cell Calcium 10(2):101-113 (Pubitemid 19065037)
18. De La Cruz JP, Blanco E, de la Sanchez Cuesta F (2000) Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 397(1):35-41 (Pubitemid 30323808)
19. Shad KF, Saeed SA (2007) The metabolism of serotonin in neuronal cells in culture and platelets. Exp Brain Res 183(3):411-416
20. Tang J, Sun Y, Wu WK, Zhong T, Liu Y, Xiao J, Tao T, Zhao Z, Gu M (2010) Propofol lowers serum PF4 level and partially corrects hypercoagulopathy in endotoxemic rats. Biochim Biophys Acta 1804(9):1895-1901
21. Silvera MJ, Smitha JB, Ingermana C, Kocsis JJ (1973) Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins 4(6):863-875
22. Koo KL, Ammit AJ, Tran VH, Duke CC, Roufoqalis BD (2001) Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation. Throm Res 103(5):387-397 (Pubitemid 32831473)
23. Maclouf J, Levy-Toledano S, Savariau E, Hardisty R, Caen JP (1984) Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase. Prostaglandins 28(3):383-398 (Pubitemid 14023452)
24. 2 and human parturition: concentrations in the plasma and production in vitro. J Endocrinol 78(3):435-441
25. Viinikka L, Ylikorkala O (1980) Measurement of thromboxane B2 in human plasma or serum by radioimmunoassay. Prostaglandins 20(4):759-766 (Pubitemid 11176180)
26. Defryn G, Deckmyn H, Vermylen J (1982) A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2. Thromb Res 26:389-400 (Pubitemid 12041221)
27. Carbaial D, Arruzazabala ML, Mas R, Molina V, Valdes S (1994) Effect of policosanol on experimental thrombosis models. Prostaglandins Leukot Essent Fatty Acids 50:249-251 (Pubitemid 24133944)
28. Mazurov AV, Menshikov MY, Leytin VL, Tkachuk VA, Repin VS (1984) Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil. FEBS Lett 172(2):167-171 (Pubitemid 14098847)
29. Sobotková A, Mášová-Chrastinová L, Suttnar J, Štikarová J, Májek P, Reicheltová Z, Kotlín R, Weisel JW, Malý M, Dyr JE (2009) Antioxidants change platelet responses to various stimulating events. Free Radic Biol Med 47:1707-1714
30. Alexandrova ML, Bochev PG (2005) Oxidative stress during the chronic phase after stroke. Free Radic Biol Med 39(3):297-316 (Pubitemid 40910187)
31. Kokoska ER, Smith GS, Deshpande Y, Wolff AB, Rieckenberg C, Miller TA (1999) Calcium accentuates injury induced by ethanol in human gastric cells. J Gastrointest Surg 3:308-318
32. Juilfs DM, Soderling S, Burns F, Beavo JA (1999) Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs). Rev Physiol Biochem Pharmacol 135:67-104
33. Matsuoka I, Nakanishi H (1985) An analysis of inhibitory effect of cyclic GMP onarachidonic acid- or collagen-induced aggregation in rabbit platelet. Thromb Res 37(1):185-193 (Pubitemid 15163086)
34. Rajendran S, Chirkov YY (2008) Platelet hyperaggregability: impaired responsiveness to nitric oxide ("platelet no resistance") as a therapeutic target. Cardiovasc Drugs Ther 22:193-203
35. Blanco F, Ferreira AM, López GV, Bonilla L, González M, Cerecetto H, Trostchansky A, Rubbo H (2011) 6-Methylnitroarachidonate: a novel esterified nitroalkene that potently inhibits platelet aggregation and exerts cGMP-mediated vascular relaxation. Free Radic Biol Med 50(3):411-418
36. Torre M, Bogetto F, Torre E (1974) Effect of LSD-25 and 1-methyl-D-lysergic acid butanolamide on rat brain and platelet serotonin levels. J Psychopharmacol 36:117-122
37. Morrell CN, Matsushita K, Chiles K, Scharpf RB, Yamakuchi M, Mason RJ (2005) Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci USA 102(10):3782-3787 (Pubitemid 40354689)
38. Ahmad G, Zemenhof S (1978) Serotonin as a growth factor for chick embryo brain. J Life Sci 22(11):963-970 (Pubitemid 8314365)
39. Chubakov AR, Tsyqanova VG, Sarkisova EF (1993) The stimulating influence of the raphe nuclei on the morphofunctional development of the hippocampus during their combined cultivation. J Neurosci Behav Physiol 23(3):271-276
40. Yamamoto Y, Haseqawa H, Inoue F, Ikeda K, Ichiyama A (1986) Serotonin in the lung. Demonstration of a close correlation to blood platelet. J Agents Action 18(3-4):351-358 (Pubitemid 16040719)
41. Cook EH Jr, Fletcher KE, Wainwright M, Marks N, Yan SY, Leventhal BL (1994) Primary structure of human platelets serotonin 5-HT receptor: identity with frontal cortex serotonin 5-HT2A receptor. J Neurochem 63(2):465-469